Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) | Title |
---|---|---|---|
PAR-25-296 | October 20, 2027 | UG3/UH3 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) |
NOT-HD-24-045 | January 1, 2027 | Notice of Change to PAR-25-148 Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | |
PAR-25-154 | July 17, 2026 | R03 | HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) |
NOT-HD-24-044 | January 1, 2027 | Notice of Intent to Publish a Funding Opportunity Announcement for Infrastructure for Population Dynamics Research Program (iPOP) (P2C Clinical Trial Not Allowed) | |
PAR-25-330 | January 8, 2028 | R01 | Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed) |
RFA-EY-25-001 | June 16, 2026 | R21 | BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
PAR-25-298 | January 8, 2028 | R15 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
RFA-HD-26-005 | March 20, 2025 | K12 | Rehabilitation Research Career Development Programs (K12 Clinical Trial Optional) |
PAR-25-242 | March 21, 2026 | R21/R33 | Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) |
PAR-25-265 | November 17, 2027 | R01 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) |
PAR-25-266 | November 17, 2027 | R21 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
PAR-25-134 | January 8, 2028 | R15 | Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
PAR-25-279 | May 8, 2027 | R01 | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) |
PAR-25-272 | May 8, 2027 | R21 | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) |
PAR-25-214 | January 8, 2026 | R21 | Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed) |
PAR-25-148 | January 8, 2028 | R15 | Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) |
RFA-NS-25-016 | June 18, 2026 | R34 | BRAIN Initiative: Promoting Equity Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed) |
PAR-25-220 | October 3, 2025 | R21 | Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) |
PAR-25-217 | October 3, 2025 | R21 | Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
PA-25-126 | January 8, 2028 | R03 | NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) |
Pagination